Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Renal Cell Carcinoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 197 Carcinoma, Non-Small-Cell Lung 61 Carcinoma, Renal Cell 51 Neoplasm Metastasis 43 Neoplasms 34 Prostatic Neoplasms 30 Uveal Melanoma 25 Lung Neoplasms 22 Carcinoma, Hepatocellular 22 Pancreatic Neoplasms 20 Sarcoma 19 Breast Neoplasms 19 Brain Neoplasms 19 Colorectal Neoplasms 18 Skin Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Small Cell Lung Carcinoma 15 Kidney Neoplasms 15 Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 12 Ovarian Neoplasms 12 Uterine Cervical Neoplasms 11 Triple Negative Breast Neoplasms 11 Mesothelioma 11 Diabetes Mellitus, Insulin-Dependent, 12 11 Recurrence 10 Head and Neck Neoplasms 10 Stomach Neoplasms 9 Multiple Myeloma 9 Glioblastoma 9

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡